Will Tesla shareholders approve Musk’s $1 trillion pay?
How is US government shutdown affecting markets?
Why did Palantir and Nvidia stocks fall recently?
What impact will Supreme Court tariff case have?
Why is Bitcoin dropping below $100K again?
How did Dem wins in NJ, VA affect markets?
Why is Pizza Hut considering a sale now?
BridgeBio's Investigation Drug Outperforms Standard Therapy In Rare Calcium Disorder
benzinga.com/news/health-care/25/10/48506974/bridgebios-investigation-drug-outperforms-standard-therapy-in-rare-calcium-disorder
BridgeBio Pharma Inc. (NASDAQ:BBIO) released topline results from the CALIBRATE Phase 3 study of encaleret in autosomal dominant hypocalcemia type 1 (ADH1) on Wednesday.
ADH1 is a genetic disorder causing low blood calcium with inappropriately low parathyroid hormone (PTH) levels.
BBIO…
This story appeared on benzinga.com, 2025-10-29 18:22:58.